Allergic encephalomyelitis - a model of allergic optic neuritis
Shul'gina, N.S.; Rabkina, L.I.; Nepomiashchaia, V.M.
Oftalmologicheskii Zhurnal 33(8): 570-573
1978
ISSN/ISBN: 0030-0675 PMID: 105333 Document Number: 139000
Document emailed within 1 workday
Related Documents
Kraft, G.H.; Slimp, J.C. 1984: Electrophysiological monitoring of experimental allergic neuritis and experimental allergic encephalomyelitis Progress in Clinical and Biological Research 146: 449-453Matsushima, S.; Yoshitoshi, T.; Mahalak, S.M.; Shichi, H. 1990: Immunosuppressive effect of gramicidin S on experimental ocular neuritis and allergic encephalomyelitis Japanese Journal of Ophthalmology 34(3): 306-313
Hahn, A.F. 1996: Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies Revue Neurologique (Paris) 152(5): 328-332
Rose, L.M.; Richards, T.; Alvord, E.C. 1994: Experimental allergic encephalomyelitis (EAE) in nonhuman primates: a model of multiple sclerosis Laboratory Animal Science 44(5): 508-512
Zaprianova, E.; Deleva, D.; Bakalska, M.; Filchev, N. 1997: Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis Morfologiia 112(6): 25-28
Samsen, P.; Chuenkongkaew, W.L.; Masayaanon, P.; Chirapapaisan, N.; Ruangvaravate, N.; Loket, S. 2007: A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis Journal of the Medical Association of Thailand 90(2): 313-318
Suzumura, A.; Sobue, G.; Sugimura, K.; Matsuoka, Y.; Sobue, I. 1982: Chronic experimental allergic neuritis as an experimental model of human idiopathic chronic polyradiculoneuropathy Rinsho Shinkeigaku 22(8): 681-689
Khizhniak, M.G.; Zhitnukhin, I.L.; Konovalov, G.V. 1987: Dynamics of pathomorphologic changes in experimental allergic encephalomyelitis Arkhiv Patologii 49(3): 54-60
Tabuchi, Y.; Irie, H.; Kanba, M.; Hikasa, C.; Takahashi, K. 1982: A study of blood nerve barrier in experimental allergic neuritis Rinsho Shinkeigaku 22(7): 616-620
Cazzullo, C.L.; Andreola, M.L.; Giordano, F.; Smeraldi, E. 1972: Mechanisms of protection against the experimental allergic encephalomyelitis in the rabbit Acta Neurologica 27(3): 213-219
Tateyama, M. 1988: Mechanism of suppression of colchicine in experimental allergic encephalomyelitis Hokkaido Journal of Medical Science 63(1): 72-79
Błaszczyk, B. 1979: Experimental allergic encephalomyelitis--clinical aspects and treatment Postepy Higieny i Medycyny Doswiadczalnej 33(1): 77-88
Zhitnukhin, I.L.; Litvinenko, I.V.; Ogurtsov, R.P. 1998: Effect of nicotinamide on development of experimental allergic encephalomyelitis Biulleten' Eksperimental'noi Biologii i Meditsiny 125(2): 180-182
Woźniak, M.; Błaszczyk, B.; Krawczyk, E.; Dobryszycka, W. 1985: Behavior of haptoglobin in experimental allergic encephalomyelitis in chickens Archivum Immunologiae et Therapiae Experimentalis 33(6): 783-788
Błaszczyk, B.; Giełdanowski, J.; Woźniak, M.; Dobryszycka, W.; Lemmel, E.M.; Katkiewicz, M.; Viljanen, M. 1988: Azimexone and cysteine hydrazide in the treatment of allergic encephalomyelitis Archivum Immunologiae et Therapiae Experimentalis 36(3): 217-227
Kasckow, J.W.; Tabira, T.; Itoyama, Y.; Kuroiwa, Y.; Takenaka, A.; Nagai, Y. 1981: Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug Japanese Journal of Experimental Medicine 51(5): 293-298
Bornstein, M.B.; Raine, C.S. 1970: Experimental allergic encephalomyelitis: inhibition of myelination and remyelination Neurology 20(4): 389
Mironova, V.N.; Vendt, V.P.; Belik, I.V.; Terletskaia, I.T.; Koval', V.G. 1977: Guinea pig spinal cord sterols in allergic encephalomyelitis Ukrains'kyi Biokhimichnyi Zhurnal 49(1): 97-100
Saida, T.; Saida, K.; Silberberg, D.H.; Brown, M.J. 1978: Transfer of demyelination by intraneural injection of experimental allergic neuritis serum Nature 272(5654): 639-641
Levine, S.; Sowinski, R. 1977: Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs Archives Internationales de Pharmacodynamie et de Therapie 230(2): 309-318